The new government in Novo Nordisk A/S’s home country of Denmark wants to test whether weight-loss drugs can help get more people into work, adding a new economic dimension to the debate over obesity treatments.
The new government in Novo Nordisk A/S’s home country of Denmark wants to test whether weight-loss drugs can help get more people into work, adding a new economic dimension to the debate over obesity treatments.
<iframe src="https://statesidedaily.com/embed/cluster/57a7c2437d7e0a0a46639e35ca9f662f4014435f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Denmark to Study Whether Wegovy Can Get More People Working"></iframe>
The new government in Novo Nordisk A/S’s home country of Denmark wants to test whether weight-loss drugs can help get more people into work, adding a new economic dimension to the debate over obesity treatments.
